Álvaro Romero-Duarte1, Mario Rivera-Izquierdo2,3,4, Inmaculada Guerrero-Fernández de Alba5,6, Marina Pérez-Contreras7, Nicolás Francisco Fernández-Martínez8,9, Rafael Ruiz-Montero8,9, Álvaro Serrano-Ortiz8,9, Rocío Ortiz González-Serna8,9, Inmaculada Salcedo-Leal8,9, Eladio Jiménez-Mejías10,11, Antonio Cárdenas-Cruz1,12. 1. School of Medicine, University of Granada, Granada, Spain. 2. Service of Preventive Medicine and Public Health, Hospital Universitario Clínico San Cecilio, Granada, Spain. mariorivera@ugr.es. 3. Department of Preventive Medicine and Public Health, University of Granada, Avda. de la Investigación n°11, 18016, Granada, Spain. mariorivera@ugr.es. 4. Instituto de Investigación Biosanitaria, ibs.GRANADA, Granada, Spain. mariorivera@ugr.es. 5. Service of Preventive Medicine and Public Health, Hospital Universitario Clínico San Cecilio, Granada, Spain. 6. Service of Preventive Medicine and Public Health, Complejo Hospitalario de Jaén, Jaén, Spain. 7. Service of Preventive Medicine and Public Health, Hospital Universitario de Puerto Real, Puerto Real, Cádiz, Spain. 8. Unidad de Gestión Clínica Interniveles de Prevención, Promoción y Vigilancia de la Salud, Hospital Universitario Reina Sofía, Córdoba, Spain. 9. Instituto Maimónides de Investigación Biomédica de Córdoba (Imibic), Córdoba, Spain. 10. Department of Preventive Medicine and Public Health, University of Granada, Avda. de la Investigación n°11, 18016, Granada, Spain. 11. Chair of Teaching and Research in Family Medicine, SEMERGEN-UGR, University of Granada, Granada, Spain. 12. Intensive Care Unit, Hospital de Poniente, El Ejido, Almería, Spain.
Abstract
BACKGROUND: Long-term effects of COVID-19, also called Long COVID, affect more than 10% of patients. The most severe cases (i.e. those requiring hospitalization) present a higher frequency of sequelae, but detailed information on these effects is still lacking. The objective of this study is to identify and quantify the frequency and outcomes associated with the presence of sequelae or persistent symptomatology (SPS) during the 6 months after discharge for COVID-19. METHODS: Retrospective observational 6-month follow-up study conducted in four hospitals of Spain. A cohort of all 969 patients who were hospitalized with PCR-confirmed SARS-CoV-2 from March 1 to April 15, 2020, was included. We collected all the SPS during the 6 months after discharge reported by patients during follow-up from primary care records. Cluster analyses were performed to validate the measures. The main outcome measures were return to the Emergency Services, hospital readmission and post-discharge death. Surviving patients' outcomes were collected through clinical histories and primary care reports. Multiple logistic regression models were applied. RESULTS: The 797 (82.2%) patients who survived constituted the sample followed, while the rest died from COVID-19. The mean age was 63.0 years, 53.7% of them were men and 509 (63.9%) reported some sequelae during the first 6 months after discharge. These sequelae were very diverse, but the most frequent were respiratory (42.0%), systemic (36.1%), neurological (20.8%), mental health (12.2%) and infectious (7.9%) SPS, with some differences by sex. Women presented higher frequencies of headache and mental health SPS, among others. A total of 160 (20.1%) patients returned to the Emergency Services, 35 (4.4%) required hospital readmission and 8 (1.0%) died during follow-up. The main factors independently associated with the return to Emergency Services were persistent fever, dermatological SPS, arrythmia or palpitations, thoracic pain and pneumonia. CONCLUSIONS: COVID-19 cases requiring hospitalization during the first wave of the pandemic developed a significant range of mid- to long-term SPS. A detailed list of symptoms and outcomes is provided in this multicentre study. Identification of possible factors associated with these SPS could be useful to optimize preventive follow-up strategies in primary care for the coming months of the pandemic.
BACKGROUND: Long-term effects of COVID-19, also called Long COVID, affect more than 10% of patients. The most severe cases (i.e. those requiring hospitalization) present a higher frequency of sequelae, but detailed information on these effects is still lacking. The objective of this study is to identify and quantify the frequency and outcomes associated with the presence of sequelae or persistent symptomatology (SPS) during the 6 months after discharge for COVID-19. METHODS: Retrospective observational 6-month follow-up study conducted in four hospitals of Spain. A cohort of all 969 patients who were hospitalized with PCR-confirmed SARS-CoV-2 from March 1 to April 15, 2020, was included. We collected all the SPS during the 6 months after discharge reported by patients during follow-up from primary care records. Cluster analyses were performed to validate the measures. The main outcome measures were return to the Emergency Services, hospital readmission and post-discharge death. Surviving patients' outcomes were collected through clinical histories and primary care reports. Multiple logistic regression models were applied. RESULTS: The 797 (82.2%) patients who survived constituted the sample followed, while the rest died from COVID-19. The mean age was 63.0 years, 53.7% of them were men and 509 (63.9%) reported some sequelae during the first 6 months after discharge. These sequelae were very diverse, but the most frequent were respiratory (42.0%), systemic (36.1%), neurological (20.8%), mental health (12.2%) and infectious (7.9%) SPS, with some differences by sex. Women presented higher frequencies of headache and mental health SPS, among others. A total of 160 (20.1%) patients returned to the Emergency Services, 35 (4.4%) required hospital readmission and 8 (1.0%) died during follow-up. The main factors independently associated with the return to Emergency Services were persistent fever, dermatological SPS, arrythmia or palpitations, thoracic pain and pneumonia. CONCLUSIONS:COVID-19 cases requiring hospitalization during the first wave of the pandemic developed a significant range of mid- to long-term SPS. A detailed list of symptoms and outcomes is provided in this multicentre study. Identification of possible factors associated with these SPS could be useful to optimize preventive follow-up strategies in primary care for the coming months of the pandemic.
Authors: Mario Rivera-Izquierdo; María Del Carmen Valero-Ubierna; Juan Luis R-delAmo; Miguel Ángel Fernández-García; Silvia Martínez-Diz; Arezu Tahery-Mahmoud; Marta Rodríguez-Camacho; Ana Belén Gámiz-Molina; Nicolás Barba-Gyengo; Pablo Gámez-Baeza; Celia Cabrero-Rodríguez; Pedro Antonio Guirado-Ruiz; Divina Tatiana Martín-Romero; Antonio Jesús Láinez-Ramos-Bossini; María Rosa Sánchez-Pérez; José Mancera-Romero; Miguel García-Martín; Luis Miguel Martín-delosReyes; Virginia Martínez-Ruiz; Pablo Lardelli-Claret; Eladio Jiménez-Mejías Journal: PLoS One Date: 2020-06-25 Impact factor: 3.240
Authors: Wim Van Damme; Ritwik Dahake; Alexandre Delamou; Brecht Ingelbeen; Edwin Wouters; Guido Vanham; Remco van de Pas; Jean-Paul Dossou; Por Ir; Seye Abimbola; Stefaan Van der Borght; Devadasan Narayanan; Gerald Bloom; Ian Van Engelgem; Mohamed Ali Ag Ahmed; Joël Arthur Kiendrébéogo; Kristien Verdonck; Vincent De Brouwere; Kéfilath Bello; Helmut Kloos; Peter Aaby; Andreas Kalk; Sameh Al-Awlaqi; N S Prashanth; Jean-Jacques Muyembe-Tamfum; Placide Mbala; Steve Ahuka-Mundeke; Yibeltal Assefa Journal: BMJ Glob Health Date: 2020-07
Authors: Aristides Tsatsakis; Daniela Calina; Luca Falzone; Dimitrios Petrakis; Radu Mitrut; Vasileios Siokas; Manuela Pennisi; Giuseppe Lanza; Massimo Libra; Sotirios G Doukas; Panagiotis G Doukas; Leena Kavali; Amar Bukhari; Chiranjeevi Gadiparthi; Dimitra P Vageli; Diamantis P Kofteridis; Demetrios A Spandidos; Monica M B Paoliello; Michael Aschner; Anca Oana Docea Journal: Food Chem Toxicol Date: 2020-09-30 Impact factor: 6.023
Authors: Ana Muñoz-Jurado; Begoña M Escribano; Eduardo Agüera; Javier Caballero-Villarraso; Alberto Galván; Isaac Túnez Journal: J Neurol Date: 2022-07-05 Impact factor: 6.682
Authors: Nicolás Francisco Fernández-Martínez; Rocío Ortiz-González-Serna; Álvaro Serrano-Ortiz; Mario Rivera-Izquierdo; Rafael Ruiz-Montero; Marina Pérez-Contreras; Inmaculada Guerrero-Fernández de Alba; Álvaro Romero-Duarte; Inmaculada Salcedo-Leal Journal: Int J Environ Res Public Health Date: 2021-08-26 Impact factor: 3.390